Using antisense oligonucleotides for the physiological modulation of the alternative splicing of NF1 exon 23a during PC12 neuronal differentiation
Abstract Neurofibromatosis Type 1 (NF1) is a genetic condition affecting approximately 1:3500 persons worldwide. The NF1 gene codes for neurofibromin protein, a GTPase activating protein (GAP) and a negative regulator of RAS. The NF1 gene undergoes alternative splicing of exon 23a (E23a) that codes...
Guardado en:
Autores principales: | Josep Biayna, Helena Mazuelas, Bernat Gel, Ernest Terribas, Gabrijela Dumbovic, Inma Rosas, Juana Fernández-Rodriguez, Ignacio Blanco, Elisabeth Castellanos, Meritxell Carrió, Conxi Lazaro, Eduard Serra |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7e2ef70d624f46fab52c22933b9b591a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Induction of cryptic pre-mRNA splice-switching by antisense oligonucleotides
por: Kristin A. Ham, et al.
Publicado: (2021) -
Antisense Oligonucleotide-Mediated Splice Switching: Potential Therapeutic Approach for Cancer Mitigation
por: Prithi Raguraman, et al.
Publicado: (2021) -
Antisense oligonucleotide modulation of non-productive alternative splicing upregulates gene expression
por: Kian Huat Lim, et al.
Publicado: (2020) -
Cationic polyelectrolyte-mediated delivery of antisense morpholino oligonucleotides for exon-skipping in vitro and in mdx mice
por: Wang M, et al.
Publicado: (2015) -
Phospholamban antisense oligonucleotides improve cardiac function in murine cardiomyopathy
por: Niels Grote Beverborg, et al.
Publicado: (2021)